lncRNAs classifier to accurately predict the recurrence of thymic epithelial tumors.
Yongchao SuYongbing ChenZuochun TianChuangang LuLiang ChenXimiao MaPublished in: Thoracic cancer (2020)
A lncRNAs classifier for patients with TETs was an independent risk factor for RFS despite other clinicopathologic variables. It generated more accurate estimations of the recurrence probability when compared to the Masaoka staging system, but additional data is required before it can be used in clinical practice.